Amira Pharmaceuticals Hits Two Development Milestones Related To FLAP Inhibitor Program
SAN DIEGO, July 19, 2010 /PRNewswire/ -- Amira Pharmaceuticals, Inc. announced today that its FLAP (5-lipoxygenase-activating protein) program, which is partnered with GlaxoSmithKline, has achieved…